Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania
- PMID: 16222009
Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania
Abstract
The efficacy of sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) was assessed at Kivunge and Micheweni in Zanzibar, Tanzania, in 2001. The main objective was to obtain baseline data after observations of high levels of chloroquine treatment failures. Children (6-59 months) were randomized to receive either drug. At Kivunge, SP and AQ were given to 64 and 63 cases, while for Micheweni, 61 and 70 cases were treated. Main findings were overall high rates (> 90%) of adequate clinical response (ACR) with AQ. A lower ACR was seen in the SP group at Kivunge (87.1%) compared with Micheweni (94.8%). Furthermore, in the ACR group, 16.7% AQ parasitological resistance (RI-RIII) was encountered at Kivunge. Most of the cases of SP parasitological resistance (14.5%; RI/RII) were seen at Micheweni. Notwithstanding this, the overall treatment failure was only 9.2% with SP and 5.5% with AQ. The Zanzibar Ministry of Health has since reviewed its antimalarial drug policy.
Similar articles
-
Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.Bull World Health Organ. 2002;80(7):538-45. Bull World Health Organ. 2002. PMID: 12163917 Free PMC article. Clinical Trial.
-
Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.Trop Med Int Health. 2005 Jun;10(6):521-9. doi: 10.1111/j.1365-3156.2005.01429.x. Trop Med Int Health. 2005. PMID: 15941414 Clinical Trial.
-
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.Am J Trop Med Hyg. 2007 Nov;77(5):947-54. Am J Trop Med Hyg. 2007. PMID: 17984359 Clinical Trial.
-
Drug resistant falciparum malaria and the use of artesunate-based combinations: focus on clinical trials sponsored by TDR.J Vector Borne Dis. 2003 Sep-Dec;40(3-4):65-72. J Vector Borne Dis. 2003. PMID: 15119074 Review.
-
Malaria: uncomplicated, caused by Plasmodium falciparum.Clin Evid. 2005 Jun;(13):988-1009. Clin Evid. 2005. PMID: 16135285 Review. No abstract available.
Cited by
-
Reductions in malaria and anaemia case and death burden at hospitals following scale-up of malaria control in Zanzibar, 1999-2008.Malar J. 2011 Feb 18;10:46. doi: 10.1186/1475-2875-10-46. Malar J. 2011. PMID: 21332989 Free PMC article.
-
Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies.Malar J. 2005 Nov 18;4:55. doi: 10.1186/1475-2875-4-55. Malar J. 2005. PMID: 16297234 Free PMC article.
-
Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.Malar J. 2012 Apr 30;11:140. doi: 10.1186/1475-2875-11-140. Malar J. 2012. PMID: 22545573 Free PMC article.
-
High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania.Malar J. 2019 Mar 25;18(1):99. doi: 10.1186/s12936-019-2740-z. Malar J. 2019. PMID: 30909922 Free PMC article.